[Translation] A randomized, open-label, endpoint-blind, positive-controlled, multicenter phase II clinical trial of tenecteplase for injection (TNK-tPA) in the treatment of acute pulmonary embolism
以注射用阿替普酶(爱通立®)作为对照评价TNK-tPA 治疗急性肺栓塞的有效性与安全性,为后续试验的剂量选择提供依据。
[Translation] To evaluate the efficacy and safety of TNK-tPA in the treatment of acute pulmonary embolism using alteplase for injection (Alteplase®) as a control, and to provide a basis for dose selection in subsequent trials.